Synergistic interaction between neuropeptide Y1 and Y5 receptor pathways in regulation of energy homeostasis
- PMID: 19482021
- DOI: 10.1016/j.ejphar.2009.05.018
Synergistic interaction between neuropeptide Y1 and Y5 receptor pathways in regulation of energy homeostasis
Abstract
Neuropeptide Y plays a key role in the physiological control of energy homeostasis. Five neuropeptide Y receptor subtypes have been cloned, and multiple neuropeptide Y receptor subtypes are thought to mediate neuropeptide Y activity. However, interactions among neuropeptide Y receptor subtypes have not been elucidated to date. Herein, we examined the interaction between neuropeptide Y(1) and Y(5) receptors in feeding regulation by employing selective neuropeptide Y(1) and Y(5) receptor antagonists in C57BL/6 and neuropeptide Y(1) receptor knockout mice fed a high-fat diet. A single-dose of a neuropeptide Y(1) receptor antagonist (10-30 mg/kg) suppressed spontaneous food intake and reduced body weight in high-fat diet-fed C57BL/6 mice, while treatment with a neuropeptide Y(5) receptor antagonist did not significantly reduce food intake or body weight. Coadministration of a neuropeptide Y(1) receptor antagonist with a neuropeptide Y(5) receptor antagonist further suppressed food intake and reduced body weight. Next, we evaluated the chronic efficacy of a neuropeptide Y(5) receptor antagonist in high-fat diet-fed neuropeptide Y(1) receptor knockout mice in order to mimic chronic combination treatment with neuropeptide Y(1) and Y(5) receptor antagonists. The neuropeptide Y(5) receptor antagonist produced greater body weight reductions in high-fat diet-fed neuropeptide Y(1) receptor knockout mice than in wild-type C57BL/6 mice. These findings confirm an interaction between neuropeptide Y(1) and Y(5) receptors in the regulation of energy homeostasis, as blockade of both the neuropeptide Y(1) and Y(5) receptors produced a greater anti-obesity effect than blocking either receptor alone.
Similar articles
-
Effects of a novel Y5 antagonist in obese mice: combination with food restriction or sibutramine.Obesity (Silver Spring). 2008 Jul;16(7):1510-5. doi: 10.1038/oby.2008.223. Epub 2008 Apr 10. Obesity (Silver Spring). 2008. PMID: 18421274
-
Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice.Peptides. 2009 Jul;30(7):1318-22. doi: 10.1016/j.peptides.2009.04.006. Epub 2009 Apr 23. Peptides. 2009. PMID: 19394383
-
Y2Y4 receptor double knockout protects against obesity due to a high-fat diet or Y1 receptor deficiency in mice.Diabetes. 2006 Jan;55(1):19-26. Diabetes. 2006. PMID: 16380472
-
Neuropeptide Y Y5 receptor antagonists as anti-obesity drugs.Curr Opin Investig Drugs. 2003 Oct;4(10):1198-204. Curr Opin Investig Drugs. 2003. PMID: 14649211 Review.
-
Modulation of neuropeptide Y receptors for the treatment of obesity.Expert Opin Ther Pat. 2009 Oct;19(10):1401-15. doi: 10.1517/13543770903251722. Expert Opin Ther Pat. 2009. PMID: 19743896 Review.
Cited by
-
Genetic association analysis of 30 genes related to obesity in a European American population.Int J Obes (Lond). 2014 May;38(5):724-9. doi: 10.1038/ijo.2013.140. Epub 2013 Jul 31. Int J Obes (Lond). 2014. PMID: 23900445 Free PMC article.
-
Targeting the Neuropeptide Y System in Stress-related Psychiatric Disorders.Neurobiol Stress. 2015 Jan 1;1:33-43. doi: 10.1016/j.ynstr.2014.09.007. Neurobiol Stress. 2015. PMID: 25506604 Free PMC article.
-
Adipose Y5R mRNA is higher in obese than non-obese humans and is correlated with obesity parameters.Exp Biol Med (Maywood). 2018 May;243(9):786-795. doi: 10.1177/1535370218774889. Exp Biol Med (Maywood). 2018. PMID: 29763369 Free PMC article. Clinical Trial.
-
Hormonal Gut-Brain Signaling for the Treatment of Obesity.Int J Mol Sci. 2023 Feb 8;24(4):3384. doi: 10.3390/ijms24043384. Int J Mol Sci. 2023. PMID: 36834794 Free PMC article. Review.
-
Regulation of hindbrain Pyy expression by acute food deprivation, prolonged caloric restriction, and weight loss surgery in mice.Am J Physiol Endocrinol Metab. 2012 Sep 1;303(5):E659-68. doi: 10.1152/ajpendo.00033.2012. Epub 2012 Jul 3. Am J Physiol Endocrinol Metab. 2012. PMID: 22761162 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials